Poland· PL-100492589
Maxitrol
A dexamethason mit antiinfektiva product containing dexamethasonum + neomycini sulfas + polymyxini b sulfas, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Dexamethasonum + Neomycini sulfas + Polymyxini B sulfas
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991529642
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01CA01
Dexamethason mit antiinfektiva, as other registers publish it.
- NetherlandsBradexa 3 mg/ml + 1 mg/ml oogdruppels, suspensieRockmed Pharma B.V.
- PolandBrazoflaminSynoptis Pharma Sp. z o.o.
- BelgiumDe Icol 4 mg/ml - 1 mg/mlViatris Healthcare
- BelgiumDetobra 1 mg/ml - 3 mg/mlViatris Healthcare
- CzechiaDEXA-GENTAMICINURSAPHARM spol. s r.o., Praha
- CzechiaDEXACHLOR
- SwitzerlandDexagenta-POS
- BelgiumDexagenta-Pos 1 mg/ml - 5 mg/mlURSAPHARM Benelux
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Polydexa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6089405-8290-4010-9d22-950e43cd4a3d GET /v1/drugs/d6089405-8290-4010-9d22-950e43cd4a3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, zawiesina",
"source": "urpl",
"strength": "(1 mg + 3500 j.m. + 6000 j.m.)/ml",
"packaging": "05909991529642 ¦ Rp ¦ 152944\n1 butelka 5 ml",
"substance": "Dexamethasonum 1 mg/ml + Neomycini sulfas 3500 j.m./ml + Polymyxini B sulfas 6000 j.m./ml",
"common_name": "Dexamethasonum + Neomycini sulfas + Polymyxini B sulfas",
"pl_product_id": "100492589",
"pozwolenie_nr": "031/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-01-22"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.